EndoRoTM Endo-navigation Robotic Arm
EndoRo Endo-navigation Robotic Arm
- Clinical Condition
- Lung cancer is the most common cancer globally, >1.82 million new cases each year and 1.59 million deaths.
- If diagnosed in Stage 1, survival rates are 50%, vs. just 1% if diagnosed in Stage 4
- Early diagnosis dramatically improves survival but is difficult due to small size of tumor nodules.
- Current Practice
- Large bronchoscopes are introduced in the airways to image and collect tissue samples (biopsy).
- Biopsies from lung periphery are obtained blindly with high risk of misdiagnosis.
- Bronchoscopes are uncomfortable and patients are exposed to radiation.
- Doctors are exposed to radiation and advanced training is difficult.
- Solution
- EndoRoTM uses EM guidance to automatically navigate the biopsy catheter to lung periphery.
- Working prototype of EndoRoTM v1.0 tested on bench model. Provisional patent filed in July 2018.
- Medical robotic surgery is predicted to reach $16.74 billion by 2023 at a CAGR of 21%.
- Unique solution, existing endovascular robots are manually operated.
